Study on the predictive efficacy of Ki-67, ER, and PR levels on the effectiveness of neoadjuvant chemotherapy in breast cancer
AimTo investigate the predictive efficacy of Ki-67 antigen (Ki-67), estrogen receptor (ER), and progesterone receptor (PR) levels on the effectiveness of neoadjuvant chemotherapy (NAC) in breast cancer.MethodsA total of 720 breast cancer patients receiving NAC at our hospital from September 2022 to...
Zapisane w:
| Główni autorzy: | , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Frontiers Media S.A.
2026-07-01
|
| Seria: | Frontiers in Medicine |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.frontiersin.org/articles/10.3389/fmed.2026.1780629/full |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|